financetom
Business
financetom
/
Business
/
Levi Strauss & Insider Sold Shares Worth $916,919, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Levi Strauss & Insider Sold Shares Worth $916,919, According to a Recent SEC Filing
Apr 2, 2024 4:58 AM

07:39 AM EDT, 04/02/2024 (MT Newswires) -- David A Friedman, Director, around March 28, 2024, sold 45,837 shares in Levi Strauss & (LEVI) for $916,919. Following the Form 4 filing with the SEC, Friedman has control over a total of 204,221 shares of the company, with 35,213 shares held directly and 169,008 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/94845/000199937124004312/xslF345X03/friedman_form4.xml

Price: 19.79, Change: -0.51, Percent Change: -2.51

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Enlivex Therapeutics Receives Approval to Expand Trial of Allocetra to Treat Knee Osteoarthritis Into Denmark
Enlivex Therapeutics Receives Approval to Expand Trial of Allocetra to Treat Knee Osteoarthritis Into Denmark
Apr 16, 2024
08:26 AM EDT, 04/16/2024 (MT Newswires) -- Enlivex Therapeutics ( ENLV ) said Tuesday that the Danish Medicines Agency has authorized the expansion of its phase 1/2 trial evaluating Allocetra in patients with moderate to severe knee osteoarthritis. The first stage of the trial will test the safety and tolerability of Allocetra injections to identify the dose and injection regimen...
What's Going On With Bank Of New York Mellon Shares After Reporting Q1 Results?
What's Going On With Bank Of New York Mellon Shares After Reporting Q1 Results?
Apr 16, 2024
The Bank Of New York Mellon Corporation ( BK ) shares are trading higher in the premarket session on Tuesday. The finance behemoth reported first-quarter adjusted earnings per share of $1.29, beating the street view of $1.19. Quarterly revenue of $4.527 billion outpaced the analyst consensus of $4.388 billion. “In the first quarter, we delivered double-digit EPS growth as well as pre-tax margin and...
Market Chatter: Mondelez Set to Be Fined by European Regulators Over Cross-Border Sales Restrictions
Market Chatter: Mondelez Set to Be Fined by European Regulators Over Cross-Border Sales Restrictions
Apr 16, 2024
08:30 AM EDT, 04/16/2024 (MT Newswires) -- Mondelez ( MDLZ ) will be fined millions of euros by the European Commission as early as May for restricting sales of its products between European Union member states, the Financial Times reported, citing unnamed sources. The maker of Oreo cookies was first asked by the EU about its alleged blocking of sales...
Lexeo Says AAV-Based Gene Therapy Candidate Gets US FDA's Fast Track Designation for Friedreich's Ataxia Cardiomyopathy
Lexeo Says AAV-Based Gene Therapy Candidate Gets US FDA's Fast Track Designation for Friedreich's Ataxia Cardiomyopathy
Apr 16, 2024
08:26 AM EDT, 04/16/2024 (MT Newswires) -- Lexeo Therapeutics ( LXEO ) said Tuesday that its AAVrh.10hFXN-based gene therapy candidate has received fast-track designation from the US Food and Drug Administration to treat Friedreich's ataxia cardiomyopathy. The candidate, LX2006, is developed to provide a functional frataxin gene for promoting frataxin protein expression and restoring mitochondrial function in myocardial cells, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved